New drugs for ovarian cancer Journal Article
| Authors: | Bell-Mcguinn, K.; Konner, J.; Tew, W.; Spriggs, D. R. |
| Article Title: | New drugs for ovarian cancer |
| Keywords: | treatment outcome; review; angiogenesis inhibitor; antineoplastic agents; antineoplastic agent; ovarian neoplasms; randomized controlled trials as topic; monoclonal antibody; antibodies, monoclonal; drug antagonism; ovary tumor; clinical trials, phase ii as topic; angiogenesis inhibitors; nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase; randomized controlled trial (topic); poly(adp-ribose) polymerases; phase 2 clinical trial (topic) |
| Journal Title: | Annals of Oncology |
| Volume: | 22 |
| Issue: | Suppl. 8 |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2011-12-01 |
| Start Page: | viii77 |
| End Page: | viii82 |
| Language: | English |
| PUBMED: | 22180408 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Export Date: 2 April 2012" - "Source: Scopus" |
Citation Impact
MSK Authors
-
155Konner -
60Bell-McGuinn -
244Tew -
325Spriggs